# FDA 483 - Novartis Pharmaceuticals Corporation - July 02, 2019

Source: https://www.globalkeysolutions.net/records/483/novartis-pharmaceuticals-corporation/c6325072-d87e-498a-b3b4-36459051caaf

> FDA 483 for Novartis Pharmaceuticals Corporation on July 02, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Novartis Pharmaceuticals Corporation
- Inspection Date: 2019-07-02
- Product Type: drugs
- Office Name: FDA District Office — Parsippany, New Jersey

## Related Documents

- [483 - 2019-07-02](https://www.globalkeysolutions.net/records/483/novartis-pharmaceuticals-corporation/f41b4987-4755-4611-8f3e-320310191701)
- [483 - 2019-07-02](https://www.globalkeysolutions.net/records/483/novartis-pharmaceuticals-corporation/674462be-82ec-4826-9df2-f767c3094372)

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/nina-yang/8d080437-2e05-4b75-8c53-b818d761cf1f)
- [Shirley S. Wen](https://www.globalkeysolutions.net/people/shirley-s-wen/eafbc8e5-a0ac-443a-adaf-ced505f77842)

Company: https://www.globalkeysolutions.net/companies/novartis-pharmaceuticals-corporation/5d9b7200-60f5-4803-80b8-0af1ba4f161c

Office: https://www.globalkeysolutions.net/offices/fda-district-office-parsippany-new-jersey/c09c7de9-a2c7-45fc-a42c-8d341c23fc86